Toggle menu

NOVEL Study

Start date:
May/June 2018
Co-ordinated by:
LUMIRADx
Main trial site:
Royal Infirmary Edinburgh

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Primary Objective: evaluation of diagnostic platform with biomarkers useful in emergency settings.

Sample: Patients over 18 years old presenting to the Emergency Department with mainly symptoms of cardiovascular conditions.

Trial Design: Prospective observational (cohort) feasibility study

Chief Investigator

Professor Alasdair Gray

Director of EMERGE & Consultant in Emergency Medicine

Research Team

Adam Lloyd

PhD Student & Senior Research Nurse

Alison Grant

Senior Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

Julia Grahamslaw

Lead Research Nurse

Polly Black

Senior Research Nurse

Mia Paderanga

Senior Research Nurse

Rachel O'Brien

Lead Research Nurse

More EMERGE Trials

Traumatic Brain Injury (TBI) is the leading cause of death and disabilities amongst young people worldwide. Many sufferers develop chronic physical and mental health problems and are unable to work or re-engage socially after their injuries. There are therefore significant health and socioeconomic consequences.

Read more

PitSTOP

A study examining the Prevalence and Risk of Anterior Pituitary Dysfunction following Traumatic Brain Injury

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA

Identification of Novel Psychoactive Substances (IONA)

Auditting, monitoring and optimising the transfusion support given to trauma patients in Scotland

Read more

Code Red

Transfusion and Laboratory support in Trauma Group Code Red Audit